Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Japan | 2020

The Japan EP mapping and ablation device market will experience moderate growth through 2029, due to favorable reimbursement for ablation procedures, increasing AF ablation procedure volumes, and the uptake of premium-priced devices. However, the COVID-19 global pandemic will have a slight impact on the Japan EP mapping and ablation device market, resulting in lost procedure volumes in the short term followed by a period of recovery.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for EP mapping and ablation devices in Japan across a 10-year period.

Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow moderately through the forecast period, driven by rising procedure volumes, anticipated product launches, and increasing affordability of…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative, higher-priced powered thrombectomy devices and their increasing adoption for treating PE—supported by favorable clinical data—will drive strong growth in the global…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…